Jeremy J Y, Mikhailidis D P, Dandona P
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):70-3. doi: 10.1007/BF00633200.
The present study shows that nifedipine, nimodipine and nisoldipine inhibit in vitro agonist-induced prostacyclin (PGI2) release from rat aortic rings. The agonists used were: U46619 (a thromboxane A2 analogue); A23187 (a calcium ionophore) and adrenaline. In contrast, these calcium channel blockers did not inhibit in vitro trauma- or arachidonic acid (AA)-induced PGI2 release. Therefore, in vitro PGI2 release models may be calcium channel dependent (adrenaline, U46619, A23187) or independent (trauma, AA), a property which is relevant to calcium channel blocker research. It is suggested that calcium channel dependent PGI2 release is relevant to modulating the relaxation phase of muscle contraction, while calcium channel independent PGI2 release is relevant to limiting the extension of thrombi following local vascular trauma.
本研究表明,硝苯地平、尼莫地平和尼索地平在体外可抑制激动剂诱导的大鼠主动脉环前列环素(PGI2)释放。所用激动剂为:U46619(一种血栓素A2类似物);A23187(一种钙离子载体)和肾上腺素。相比之下,这些钙通道阻滞剂在体外不抑制创伤或花生四烯酸(AA)诱导的PGI2释放。因此,体外PGI2释放模型可能是钙通道依赖性的(肾上腺素、U46619、A23187)或非依赖性的(创伤、AA),这一特性与钙通道阻滞剂的研究相关。提示钙通道依赖性PGI2释放与调节肌肉收缩的舒张期有关,而钙通道非依赖性PGI2释放与限制局部血管创伤后血栓的扩展有关。